Y-mAbs Therapeutics, Inc. (20) | Uncategorized (6)

Recent Contracts

Description of the registrants securities registered pursuant to section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 1, 2022)
Description of the registrants securities registered pursuant to section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 1, 2021)
Master Sponsored Research Agreement effective as of October 7, 2020 by and between the Company and Memorial Sloan Kettering Cancer Center (Filed With SEC on October 8, 2020)
Description of the registrants securities registered pursuant to section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 12, 2020)
Y-mAbs Sublicense Agreement, dated as of June 27, 2018, by and between the Company and MabVax Therapeutics Holdings, Inc (Filed With SEC on December 19, 2019)
Amended and Restated Sponsored Research Agreement effective as of September 13, 2019 by and between the Company and Memorial Sloan Kettering Cancer Center (Filed With SEC on September 19, 2019)